aTyr Pharma Competitors and Similar CompaniesClear all
Aerie Pharmaceuticals's competitors and similar companies include Merus.
 Aerie Pharmaceuticals Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. |  Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. | |
Founding Date | Founding Date 2005 | Founding Date 2003 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Irvine, US HQ Dublin, IE 千代田区, JP Henley On Thames, GB Bedminster, US Durham, US | Locations Utrecht, NL HQ Cambridge, US |
Employees | Employees 3808% increase | Employees 260 |
Valuation ($) | Valuation ($) 722.2 m | Valuation ($) 3.6 b |
Financial | ||
Revenue (est.) | Revenue (est.) $194.1m (FY, 2021) | Revenue (est.) $36.1m (FY, 2024) |
Cost of goods | Cost of goods $26.8m (FY, 2021) | Cost of goods N/A |
Net income | Net income ($74.8m) (FY, 2021) | Net income ($215.3m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 388.6m | Total funding raised $ 149.3m |
For sources of this data, please see the company profile
View Company Profiles
Merus
HQ
Utrecht, NL
Employees
260
Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
View company